Kolumne, ORE

Original-Research: Avemio AG - from GBC AG Classification of GBC AG to Avemio AG Company Name: Avemio AG ISIN: DE000A2LQ1P6 Reason for the research: Research Report (Anno) Recommendation: BUY Target price: 23,00 EUR Target price on sight of: 31.12.2025 Last rating change: Analyst: Cosmin Filker; Niklas Ripplinger - Transformation into a media technology group is being driven forward - Improvement in profit margins expected With the presentation of the consolidated figures for the first time, Avemio AG reported sales of EUR 99.15 million for the past financial year 2023.

15.07.2024 - 10:02:32

Original-Research: Avemio AG (von GBC AG): BUY


Original-Research: Avemio AG - from GBC AG

Classification of GBC AG to Avemio AG

Company Name: Avemio AG
ISIN: DE000A2LQ1P6

Reason for the research: Research Report (Anno)
Recommendation: BUY
Target price: 23,00 EUR
Target price on sight of: 31.12.2025
Last rating change: 
Analyst: Cosmin Filker; Niklas Ripplinger

- Transformation into a media technology group is being driven forward
- Improvement in profit margins expected
 
With the presentation of the consolidated figures for the first time,
Avemio AG reported sales of EUR 99.15 million for the past financial year
2023. Although no comparative figures are available for the 2022 financial
year, the pro forma figures we have calculated (revenue according to GBC
calculation: EUR 108.70 million) indicate a downward business trend. The
company had originally assumed sales of EUR 120 million for the past
financial year.
 
The lower-than-expected sales trend is due in particular to weaker demand
in the second half of the year, reflecting the low propensity to invest as
a result of the economic situation. Overall, demand was lower, particularly
for higher-priced equipment and on the consumer side. This was exacerbated
by a lack of innovation and therefore a lack of incentives to buy. Finally,
the high level of investment during the coronavirus pandemic led to
pull-forward effects.
 
As expected, EBITDA was also below expectations at EUR -0.05 million
(previous year according to GBC calculation: EUR 4.44 million) (Avemio
guidance: EUR 5 million). While the gross profit margin remained stable,
operating expenses rose disproportionately to gross profit. Among other
things, this is due to the expansion of personnel capacities and increased
product development costs for the Avemio companies focussing on digital
services. Lower than expected sales from these start-ups were also
accompanied by a lack of earnings contributions.
 
According to the company's guidance, sales growth of between 1% and 4% is
to be achieved in the current 2024 financial year. EBIT (2023: EUR -2.61
million) is expected to increase disproportionately to break-even level.
While sales in the retail business are expected to decline by 2% due to the
ongoing reluctance to invest, sales in the media technology segment are
expected to increase. The expansion of the media technology segment is in
any case an important pillar of the corporate strategy, which aims to
improve customer loyalty on the one hand and increase the quality of
earnings on the other. This strategic component is very well represented by
the acquisition of MoovIT GmbH, with which the product range was expanded
to include the areas of system integration and software development as well
as consulting services for the optimisation and automation of video
workflows. However, in-house developments driven by majority-owned
start-ups will also contribute to the planned change.
 
For the current financial year, we expect sales revenue of EUR 101.14 million
(sales growth: 2.0%) and also assume constant sales growth of 7.0% p.a. for
the coming financial years (2025 and 2026). The full-year inclusion of the
media technology subsidiary MoovIT and the marketing of the digital
products developed by Avemio AG should lead to an improvement in the profit
margin. In addition, Avemio AG has implemented cost-cutting measures that
should take full effect from 2025 in particular. We expect the EBIT margin
to improve to 6.1% by 2026.
 
We have determined a new price target of EUR 23.00, which corresponds to a
reduction of the previous price target of EUR 32.00. The lower price target
results from the reduced forecasts for the current financial year 2024,
which have led to a reduction in the estimates for the coming financial
years. We have also reduced our long-term target EBITDA margin expectation
to 10.0% (previously: 11.6%). We continue to assign a BUY rating.
 

You can download the research here:
http://www.more-ir.de/d/30213.pdf

Contact for questions
GBC AG
Halderstraße 27
86150 Augsburg
0821 / 241133 0
research@gbc-ag.de
++++++++++++++++
Disclosure of potential conflicts of interest pursuant to Section 85 WpHG and Art. 20 MAR The company analysed above has the following potential conflict of interest: (5a,11); A catalogue of potential conflicts of interest can be found at 
https://www.gbc-ag.de/de/Offenlegung
+++++++++++++++
Date and time of completion of the study: 15.07.2024 (08:39 am)
Date and time of publication of the study: 15.07.2024 (10:00 am)

-------------------transmitted by EQS Group AG.-------------------


The issuer is solely responsible for the content of this research.
The result of this research does not constitute investment advice
or an invitation to conclude certain stock exchange transactions.

@ dpa.de

Weitere Meldungen

Original-Research: ParTec AG (von First Berlin Equity Research GmbH): Buy Original-Research: ParTec AG - from First Berlin Equity Research GmbH 22.11.2024 / 11:20 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 11:21) weiterlesen...

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research... Original-Research: Cardiol Therapeutics Inc - from First Berlin Equity Research GmbH 22.11.2024 / 11:05 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 11:06) weiterlesen...

Original-Research: ad pepper media International N.V. (von First Berlin Equit... Original-Research: ad pepper media International N.V. - from First Berlin Equity Research GmbH 22.11.2024 / 10:45 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 10:46) weiterlesen...

Original-Research: NFON AG (von NuWays AG): Buy Original-Research: NFON AG - from NuWays AG 22.11.2024 / 09:05 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 09:06) weiterlesen...

Original-Research: Nabaltec AG (von NuWays AG): Buy Original-Research: Nabaltec AG - from NuWays AG 22.11.2024 / 09:01 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 09:02) weiterlesen...

Original-Research: mVISE AG (von NuWays AG): Buy Original-Research: mVISE AG - from NuWays AG 22.11.2024 / 09:01 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 09:01) weiterlesen...